Genome Insight

Genome Insight is a bioinformatics-led company, founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, that harnesses whole genome data and proprietary analytics to deliver curated insights advancing precision health. It serves researchers, providers, and patients, and operates a CLIA certified and CAP accredited lab. Its whole genome tests include CancerVision, a target-enhanced whole genome sequencing test that profiles solid tumor cancers.

Genome Insight was founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians. Since then, the company has developed IP-protected technology and a proprietary whole genome insight platform while achieving operational excellence in its CLIA certified and CAP accredited lab. It also brings innovation in delivery through patient-centric services that provide access to genetic counseling and clinical trial matching support.

Whole genome power. Whole patient impact. Curated whole genome insights. Actionable answers.

• CancerVision

  Target-enhanced whole genome sequencing test that profiles solid tumor cancers; a 2-in-1 somatic + germline paired test with >99% sensitivity/positive predictive value and accurate complex variants detection (SV, CNV, non-coding areas), offering TMB, MSI, HRD, mutational signatures, and germline variant detection.

1. 1Inocras - Curated whole genome insights. Actionable answers.inocras.com
2. 2About - Inocrasinocras.com
3. 3Genome Insight (South Korea)wikidata.org